Frontiers in Drug Delivery | Respiratory Drug Delivery

Original Research

Published on 11 Nov 2024

Targeting aerosol delivery to regions of nasal-associated lymphoid tissue (NALT) in three dimensional models of human intranasal airways using the BiVax intranasal atomizer

in Respiratory Drug Delivery

Beth L. Laube
Jana Kesavan
Gonçalo Farias
Nektaria Karavas
Mathilde Blondel
Julie Suman

Frontiers in Drug Delivery

doi 10.3389/fddev.2024.1456538

494 views

Review

Published on 08 Jan 2024

Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects

in Respiratory Drug Delivery

Taiwo Oreoluwa Ajayi
Madan Sai Poka
Bwalya Angel Witika

Frontiers in Drug Delivery

doi 10.3389/fddev.2023.1295815

2,176 views

Editorial

Published on 19 Jul 2023

Editorial: Strategies to overcome the barriers to effective inhaled treatments

in Respiratory Drug Delivery

Philip Chi Lip Kwok
Mohammad A. M. Momin
Basanth Babu Eedara
Shing Fung Chow

Frontiers in Drug Delivery

doi 10.3389/fddev.2023.1253709

929 views

Review

Published on 14 Jun 2023

Design of respirable sprayed microparticles of encapsulated bacteriophages

in Respiratory Drug Delivery

Alberto Baldelli
Mingtao Liang

Frontiers in Drug Delivery

doi 10.3389/fddev.2023.1209534

1,960 views
4 citations

Original Research

Published on 30 May 2023

On a model-based approach to improve intranasal spray targeting for respiratory viral infections

in Respiratory Drug Delivery

Mohammad Mehedi Hasan Akash
Yueying Lao
Pallavi A. Balivada
Phoebe Ato
Nogaye K. Ka
Austin Mituniewicz
Zachary Silfen
Julie D. Suman
Arijit Chakravarty
Diane Joseph-McCarthy

Frontiers in Drug Delivery

doi 10.3389/fddev.2023.1164671

2,894 views
5 citations

Review

Published on 03 Oct 2022

Mesh nebulizers enabling transnasal pulmonary delivery of medical aerosols to infants and toddlers: Roles, challenges, and opportunities

in Respiratory Drug Delivery

Arzu Ari
Bruce K. Rubin
James B. Fink

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.995489

3,672 views
3 citations

Original Research

Published on 11 Jul 2022

Inhalable Composite Microparticles Containing siRNA-Loaded Lipid-Polymer Hybrid Nanoparticles: Saccharides and Leucine Preserve Aerosol Performance and Long-Term Physical Stability

in Respiratory Drug Delivery

You Xu
Enise Tugba Turan
Zhenning Shi
Henrik Franzyk
Aneesh Thakur
Camilla Foged

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.945459

1,893 views
5 citations

General Commentary

Published on 23 May 2022

Commentary: Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?

in Respiratory Drug Delivery

Igor Gonda

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.896342

1,218 views

Brief Research Report

Published on 04 May 2022

In Vitro Estimation of Tracheobronchial and Alveolar Doses Using Filters

in Respiratory Drug Delivery

Warren H. Finlay
Dino J. Farina
Scott Tavernini
Andrew R. Martin

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.901289

1,393 views
4 citations

Mini Review

Published on 13 Apr 2022

Half a Century of Technological Advances in Pulmonary Drug Delivery: A Personal Perspective

in Respiratory Drug Delivery

Andrew R. Clark

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.871147

8,401 views
10 citations

Original Research

Published on 06 Apr 2022

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder

in Respiratory Drug Delivery

Helena Gauani
Thomas Baker
Zhili Li
Vladimir S. Malinin
Walter Perkins
Eugene Sullivan
David Cipolla

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.864922

4,178 views
5 citations

Opinion

Published on 22 Mar 2022

Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?

in Respiratory Drug Delivery

Jeffry Weers

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.855234

4,094 views
2 citations

Original Research

Published on 15 Mar 2022

Formulation of Dry Powders for Inhalation Comprising High Doses of a Poorly Soluble Hydrophobic Drug

in Respiratory Drug Delivery

Thomas E. Tarara
Danforth P. Miller
Audrey E. Weers
Ariel Muliadi
Jerry Tso
Avi Eliahu
Jeffry G. Weers

Frontiers in Drug Delivery

doi 10.3389/fddev.2022.862336

8,279 views
15 citations

Navigation group

Articles

Targeting aerosol delivery to regions of nasal-associated lymphoid tissue (NALT) in three dimensional models of human intranasal airways using the BiVax intranasal atomizer

Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects

Editorial: Strategies to overcome the barriers to effective inhaled treatments

Design of respirable sprayed microparticles of encapsulated bacteriophages

On a model-based approach to improve intranasal spray targeting for respiratory viral infections

Mesh nebulizers enabling transnasal pulmonary delivery of medical aerosols to infants and toddlers: Roles, challenges, and opportunities

Inhalable Composite Microparticles Containing siRNA-Loaded Lipid-Polymer Hybrid Nanoparticles: Saccharides and Leucine Preserve Aerosol Performance and Long-Term Physical Stability

Commentary: Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?

In Vitro Estimation of Tracheobronchial and Alveolar Doses Using Filters

Half a Century of Technological Advances in Pulmonary Drug Delivery: A Personal Perspective

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder

Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?

Formulation of Dry Powders for Inhalation Comprising High Doses of a Poorly Soluble Hydrophobic Drug